Aflac Inc offers supplemental health insurance and life insurance in the United States and Japan... Show more
Aflac Incorporated (AFL), one of the largest providers of supplemental health and life insurance in the United States and Japan, maintains a well-established dividend policy. The company pays a quarterly cash dividend of $0.61 per share, which translates to an annualized payout of about $2.44 per share and a dividend yield near 2.1% at recent price levels.
Aflac is best characterized as a dividend growth stock rather than a high-yield stock. Its yield is modest compared with income-focused sectors, but the company has built a decades-long record of consistently raising its payout. Management's commitment to returning capital to shareholders is reinforced by an active share repurchase program, which helps support per-share dividend growth over time.
Aflac's dividend history is among the most consistent in the insurance industry. The company has increased its dividend for 43 consecutive years, a streak that places it in an elite group of dividend growers. Its most recent increase took effect in early 2026, when the quarterly dividend was raised 5.2% from $0.58 to $0.61 per share.
Growth has been particularly strong in recent years. Over the past five years, Aflac's dividend has grown at an annualized rate of roughly 15%, reflecting both solid earnings and a disciplined capital-return strategy. This combination of reliability and above-average growth has made AFL a favored name among investors who prioritize steadily rising income over time.
Aflac's dividend appears highly sustainable. The company's payout ratio—the share of earnings distributed as dividends—stands at roughly 26% to 31%, a conservative level that leaves substantial earnings retained for reinvestment, buybacks, and future dividend increases. Cash-flow-based coverage is similarly comfortable, indicating that the dividend is well supported by the company's actual operating cash generation.
Aflac's financial foundation supports this record. As an established supplemental insurer with a strong presence in the U.S. and Japan, the company generates steady premium income and maintains solid capital reserves. Its conservative payout and disciplined balance sheet provide a meaningful margin of safety, meaning the dividend is not dependent on aggressive leverage or an unsustainable portion of earnings.
Within the life and health insurance space, Aflac's roughly 2.1% yield sits in the middle of the pack. It is generally comparable to, and in some cases modestly below, the yields offered by other major insurers such as MetLife (MET), Prudential Financial (PRU), and Unum Group (UNM), while remaining below the higher yields often found among some financial-sector dividend payers.
Where Aflac stands out is not its current yield but its consistency of growth. Few peers can match a four-decade streak of annual increases combined with a low payout ratio. For investors, this means AFL trades a slightly lower starting yield for a stronger track record of dependable, growing income—an attractive trade-off for long-term holders.
Tickeron's AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener can also help identify dividend stocks, income-focused investments, trending names, and breakout candidates more efficiently than manual screening. For those researching names like Aflac, it offers a streamlined way to surface opportunities and compare candidates across the market.
AFL is likely to appeal most to dividend growth investors and long-term, conservative investors who value reliability over maximum current yield. The company's 43-year streak of dividend increases, combined with a low payout ratio and steady cash generation, makes it a candidate for investors building income streams intended to grow over years or decades.
For pure income investors seeking a high starting yield, Aflac's roughly 2.1% yield may be less compelling relative to higher-yielding alternatives. However, the trade-off is meaningful: the dividend has historically grown at a healthy pace, which can lift the effective yield on an investor's original cost over time.
As with any equity, Aflac carries risks, including exposure to Japan's economy and yen exchange rates, which can influence results. Investors should weigh the company's dividend reliability and growth history against their own income needs, time horizon, and risk tolerance rather than treating the stock as a guaranteed income source.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
a provider of supplemental life and health insurance services
Industry LifeHealthInsurance